Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024GlobeNewsWire • 03/20/24
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS TrustGlobeNewsWire • 01/24/24
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & GlaucomaGlobeNewsWire • 01/11/24
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted CyclophotocoagulationGlobeNewsWire • 12/28/23
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of CyclophotocoagulationGlobeNewsWire • 11/27/23
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023GlobeNewsWire • 11/13/23